Blood Glucose Monitoring Market Overview
The blood glucose monitoring market to obtain a growth rate of 7.1% during the forecast period. The drastic surge in obesity worldwide has driven the upward trend in prediabetes and diabetes diagnosis, characterized by poor glucose control. Generally preventable, the condition and its surging prevalence has become a major concern across the globe. The National Diabetes Report reveals that 15.5% of Americans, with 16% of adults, have diabetes, with around 36.5% prediabetic. These numbers are even more alarming around the world, with 470 million individuals affected by diabetes. These factors have compelled people to take up more proactive measures in order to keep their glucose levels in check, giving rise to the demand for advanced blood glucose monitoring devices.
The global blood glucose monitoring market would also benefit from the frequent technological developments along with the early detection of hyper and hypoglycemic diabetes. The changes in people’s lifestyle and the excessive intake of tobacco and alcohol have raised the number of diabetes patients drastically. This factor is touted to have a positive impact on the growth prospects of the global industry in the ensuing years.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/557
Blood Glucose Monitoring Market Segmental Analysis
The market for blood glucose monitoring devices can be divided into product type, application, as well as end user.
The major product types studied in the MRFR research report are flash glucose monitoring devices, continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, and others.
Applications of blood glucose monitoring devices are type 1 diabetes, along with type 2 diabetes, and more.
The top end users of blood glucose monitoring devices include hospitals, clinics, diagnostic centers, home care diagnostics, and research centers.
Blood Glucose Monitoring Market Regional Study
America commands the biggest share in the blood glucose monitoring market, thanks to the dramatic increase in incidences of unhealthy diet, as well as physical inactivity, followed by obesity. The United States has a highly developed healthcare sector, which should work in the market’s favor. Another factor that further cements the market position could be the soaring deployment of smart monitoring devices. With a massive pool of renowned medical device developers based in the region as well as the surging cases of diabetes, the need for advanced smart blood glucose monitoring devices should rise substantially in the next few years.
Asia Pacific presents lucrative opportunities to blood glucose monitoring manufacturers, in view of the rapidly burgeoning elderly patient base affected by diabetes. The regional blood glucose monitoring market should experience the fastest growth in the next few years, thanks to the advances in the healthcare infrastructure along with massive demand for smart devices. The rising public awareness about the latest blood glucose monitors, advances in the medical device segment, heightened government backing, and the development in R&D infrastructures should further add significantly to the blood glucose monitoring market worth in the following years.
Blood Glucose Monitoring Market Key Players
Goldsite Diagnostics Inc., GlySure Ltd (U.K), Dexcom Inc. (U.S.), LifeScan, Inc. (U.S.), Bayer Healthcare AG (Germany), F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (U.S.), Arkay, Inc. (U.S.), Sphere Medical Holding plc. (U.K), are the important blood glucose monitoring manufacturers identified in the MRFR review report.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/blood-glucose-monitoring-market-557
Blood Glucose Monitoring Market Latest Updates
Senseonics Holdings Inc., an affluent medical technology firm that develops and manufactures implantable, long-term continuous glucose monitoring (CGM) devices for patients affected by diabetes, has been given the approval by the Food and Drug Administration (FDA) for its next-generation innovative Eversense E3 CGM System. The Eversense E3 that includes the sacrificial boronic acid (SBA) technology for higher longevity of up to 6 months, should be available in the U.S. market via Ascensia Diabetes Care, which is the company’s commercial partner, by the second quarter of 2022.
Browse Related Reports at:
Healthcare Consulting Services Market Research Report – Global Forecast till 2027
Preclinical CRO Market Research Report – Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071